1. United States
2. Ariz.
3. Letter

I am writing to alert you to the severe impact that the new CBP entry requirements detailed in Indefinite Suspension of the De Minimis Exemption for Mail Shipments and New Postal Informal Entry Process will have on Americans’ ability to get needed personal-use prescription medications imported from licensed pharmacies overseas. Under these surprise new requirements, beginning October 22, medications sent by pharmacies outside the United States will be blocked from entry. This will prohibit prescription shipments of daily medications from these licensed pharmacies - even when the medications are safe, legal in the country of origin, and prescribed by a licensed physician. The restrictions are expected to apply to pharmaceutical parcels sent by pharmacies anywhere outside the U.S. - if the medication is already sold in the U.S. at a much higher price or if the seller happens to be promoting to Americans. If this rule takes effect as written or in its current form, Americans will be forced to make tough decisions about their healthcare. Purchasing medications from these licensed pharmacies is often the only viable option because medications are unreasonably expensive here in the U.S. I respectfully ask you to use your influence with CBP and the Administration to exempt personal-use prescription medications from this proposed rule. Otherwise, starting October 22, a public health crisis will emerge in which potentially millions of patients lose the only genuine option they’ve had to maintain the necessary medication treatments prescribed by doctors. Thanks.